106 related articles for article (PubMed ID: 38155023)
21. Evaluation of Penalized-Likelihood Estimation Reconstruction on a Digital Time-of-Flight PET/CT Scanner for
Lindström E; Sundin A; Trampal C; Lindsjö L; Ilan E; Danfors T; Antoni G; Sörensen J; Lubberink M
J Nucl Med; 2018 Jul; 59(7):1152-1158. PubMed ID: 29449445
[TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.
Sah BR; Stolzmann P; Delso G; Wollenweber SD; Hüllner M; Hakami YA; Queiroz MA; Barbosa FG; von Schulthess GK; Pietsch C; Veit-Haibach P
Nucl Med Commun; 2017 Jan; 38(1):57-66. PubMed ID: 27755394
[TBL] [Abstract][Full Text] [Related]
23. The association of tumor-to-background ratios and SUVmax deviations related to point spread function and time-of-flight F18-FDG-PET/CT reconstruction in colorectal liver metastases.
Rogasch JM; Steffen IG; Hofheinz F; Großer OS; Furth C; Mohnike K; Hass P; Walke M; Apostolova I; Amthauer H
EJNMMI Res; 2015; 5():31. PubMed ID: 25992306
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
25. Semi-automated
Keijzer K; Niezink AGH; de Boer JW; van Doesum JA; Noordzij W; van Meerten T; van Dijk LV
Comput Struct Biotechnol J; 2023; 21():1102-1114. PubMed ID: 36789266
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of PET parameters in patients with pleomorphic lung cancer: Results from a single institution.
Di Stasio GD; Travascio L; Colandrea M; Spaggiari L; Sorbello S; Ferrari ME; Maisonneuve P; Galetta D; Travaini L; Grana CM
Lung Cancer; 2021 Aug; 158():40-46. PubMed ID: 34111568
[TBL] [Abstract][Full Text] [Related]
27. To Determine the Prognostic Significance of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan-Derived Parameters (Total Lesion Glycolysis and Metabolic Tumor Volume) in Patients of Diffuse Large B-Cell Lymphoma with Only Nodal Involvement.
Gupta N; Singh N
Indian J Nucl Med; 2020; 35(2):100-104. PubMed ID: 32351262
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
29. Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.
Messerli M; Kotasidis F; Burger IA; Ferraro DA; Muehlematter UJ; Weyermann C; Kenkel D; von Schulthess GK; Kaufmann PA; Huellner MW
Br J Radiol; 2019 Apr; 92(1096):20180792. PubMed ID: 30673302
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial.
van Heek L; Weindler J; Gorniak C; Kaul H; Müller H; Mettler J; Baues C; Fuchs M; Borchmann P; Ferdinandus J; Dietlein M; Voltin CA; Kobe C; Roth KS
Eur J Haematol; 2023 Dec; 111(6):881-887. PubMed ID: 37644732
[TBL] [Abstract][Full Text] [Related]
31. The value of Bayesian penalized likelihood reconstruction for improving lesion conspicuity of malignant lung tumors on
Kurita Y; Ichikawa Y; Nakanishi T; Tomita Y; Hasegawa D; Murashima S; Hirano T; Sakuma H
Ann Nucl Med; 2020 Apr; 34(4):272-279. PubMed ID: 32060780
[TBL] [Abstract][Full Text] [Related]
32. Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.
van Heek L; Stuka C; Kaul H; Müller H; Mettler J; Hitz F; Baues C; Fuchs M; Borchmann P; Engert A; Dietlein M; Voltin CA; Kobe C
BMC Cancer; 2022 Jun; 22(1):672. PubMed ID: 35717166
[TBL] [Abstract][Full Text] [Related]
33. Verification of the tumor volume delineation method using a fixed threshold of peak standardized uptake value.
Koyama K; Mitsumoto T; Shiraishi T; Tsuda K; Nishiyama A; Inoue K; Yoshikawa K; Hatano K; Kubota K; Fukushi M
Radiol Phys Technol; 2017 Sep; 10(3):311-320. PubMed ID: 28676945
[TBL] [Abstract][Full Text] [Related]
34. Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study.
Takahashi N; Yamamoto T; Matsushita H; Sugawara T; Kubozono M; Umezawa R; Ishikawa Y; Kozumi M; Katagiri Y; Tasaka S; Takeda K; Takeda K; Dobashi S; Jingu K
J Radiat Res; 2016 Nov; 57(6):655-661. PubMed ID: 27422935
[TBL] [Abstract][Full Text] [Related]
35. Tumor volume-adapted SUV
Mosleh-Shirazi MA; Nasiri-Feshani Z; Ghafarian P; Alavi M; Haddadi G; Ketabi A
Jpn J Radiol; 2021 Aug; 39(8):811-823. PubMed ID: 33880686
[TBL] [Abstract][Full Text] [Related]
36. Validation of a Multifocal Segmentation Method for Measuring Metabolic Tumor Volume in Hodgkin Lymphoma.
Camacho MR; Etchebehere E; Tardelli N; Delamain MT; Vercosa AFA; Takahashi MES; Brunetto SQ; Metze IGHL; Souza CA; Cerci JJ; Ramos CD
J Nucl Med Technol; 2020 Mar; 48(1):30-35. PubMed ID: 31604902
[TBL] [Abstract][Full Text] [Related]
37. A new method for segmentation of FDG PET metabolic tumour volume using the peritumoural halo layer and a 10-step colour scale. A study in patients with papillary thyroid carcinoma.
Jun S; Kim H; Nam HY
Nuklearmedizin; 2015; 54(6):272-85. PubMed ID: 26429587
[TBL] [Abstract][Full Text] [Related]
38. Impact of point spread function modelling and time of flight on FDG uptake measurements in lung lesions using alternative filtering strategies.
Armstrong IS; Kelly MD; Williams HA; Matthews JC
EJNMMI Phys; 2014 Dec; 1(1):99. PubMed ID: 26501457
[TBL] [Abstract][Full Text] [Related]
39. Association between textural and morphological tumor indices on baseline PET-CT and early metabolic response on interim PET-CT in bulky malignant lymphomas.
Ben Bouallègue F; Tabaa YA; Kafrouni M; Cartron G; Vauchot F; Mariano-Goulart D
Med Phys; 2017 Sep; 44(9):4608-4619. PubMed ID: 28513853
[TBL] [Abstract][Full Text] [Related]
40. Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
Xu W; Yu S; Ma Y; Liu C; Xin J
Nucl Med Commun; 2017 Mar; 38(3):259-265. PubMed ID: 28118260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
